These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16315369)

  • 1. Predictors of hypertension and changes of blood pressure in HIV-infected patients.
    Thiébaut R; El-Sadr WM; Friis-Møller N; Rickenbach M; Reiss P; Monforte AD; Morfeldt L; Fontas E; Kirk O; De Wit S; Calvo G; Law MG; Dabis F; Sabin CA; Lundgren JD;
    Antivir Ther; 2005; 10(7):811-23. PubMed ID: 16315369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
    Byonanebye DM; Polizzotto MN; Neesgaard B; Sarcletti M; Matulionyte R; Braun DL; Castagna A; de Wit S; Wit F; Fontas E; Vehreschild JJ; Vesterbacka J; Greenberg L; Hatleberg C; Garges H; Gallant J; Volny Anne A; Öllinger A; Mozer-Lisewska I; Surial B; Spagnuolo V; Necsoi C; van der Valk M; Mocroft A; Law M; Ryom L; Petoumenos K;
    HIV Med; 2022 Sep; 23(8):895-910. PubMed ID: 35233903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
    Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
    HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study.
    Rodríguez-Arbolí E; Mwamelo K; Kalinjuma AV; Furrer H; Hatz C; Tanner M; Battegay M; Letang E;
    PLoS One; 2017; 12(3):e0172089. PubMed ID: 28273105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure trajectories and the mediated effects of body mass index and HIV-related inflammation in a mixed cohort of people with and without HIV in rural Uganda.
    Okello S; Kim JH; Sentongo RN; Tracy R; Tsai AC; Kakuhikire B; Siedner MJ
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1230-1241. PubMed ID: 31278845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy.
    Chow DC; Souza SA; Chen R; Richmond-Crum SM; Grandinetti A; Shikuma C
    HIV Clin Trials; 2003; 4(6):411-6. PubMed ID: 14628284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study.
    Manner IW; Baekken M; Oektedalen O; Os I
    Blood Press; 2012 Oct; 21(5):311-9. PubMed ID: 22564000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors among ART-experienced people with HIV in South Africa.
    Hyle EP; Bekker LG; Martey EB; Huang M; Xu A; Parker RA; Walensky RP; Middelkoop K
    J Int AIDS Soc; 2019 Apr; 22(4):e25274. PubMed ID: 30990252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy.
    Crane HM; Van Rompaey SE; Kitahata MM
    AIDS; 2006 Apr; 20(7):1019-26. PubMed ID: 16603854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
    Hatleberg CI; Ryom L; d'Arminio Monforte A; Fontas E; Reiss P; Kirk O; El-Sadr W; Phillips A; de Wit S; Dabis F; Weber R; Law M; Lundgren JD; Sabin C;
    HIV Med; 2018 Oct; 19(9):605-618. PubMed ID: 30019813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS).
    Nüesch R; Wang Q; Elzi L; Bernasconi E; Weber R; Cavassini M; Vernazza P; Thurnheer MC; Calmy A; Battegay M; Bucher HC;
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):396-404. PubMed ID: 23288033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti.
    Batavia AS; Severe P; Lee MH; Apollon A; Zhu YS; Dupnik KM; McNairy ML; Pape JW; Fitzgerald DW; Peck RN
    J Hypertens; 2018 Jul; 36(7):1533-1539. PubMed ID: 29634661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.
    Bakal DR; Coelho LE; Luz PM; Clark JL; De Boni RB; Cardoso SW; Veloso VG; Lake JE; Grinsztejn B
    J Antimicrob Chemother; 2018 Aug; 73(8):2177-2185. PubMed ID: 29722811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis.
    Kent ST; Bromfield SG; Burkholder GA; Falzon L; Oparil S; Overton ET; Mugavero MJ; Schwartz JE; Shimbo D; Muntner P
    PLoS One; 2016; 11(2):e0148920. PubMed ID: 26882469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of pharmaceutical care intervention in HIV positive patients with hypertension: A randomized controlled study.
    Jackson IL; Ukwe CV
    J Clin Pharm Ther; 2021 Aug; 46(4):1083-1094. PubMed ID: 33666264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.